BioNTech SE 2021 AR2
The report highlights BioNTech's extraordinarily successful 2021 financial year, marked by its historic contribution to containing the COVID-19 pandemic through the delivery of approximately 2.6 billion vaccine doses globally. The company transitioned into a fully integrated biopharmaceutical powerhouse, recording EUR 19 billion in revenues and expanding its global footprint. In oncology, BioNTech advanced its pipeline with four randomized Phase 2 trials and five first-in-human studies. Additionally, the company committed to climate protection by setting targets aligned with the Science Based Targets initiative, aiming for a 42% reduction in Scope 1 and 2 emissions by 2030.
Company: BioNTech SE
Sector: Professional & technical services
Country: Germany
Year: 2021
Type: AR2
Pages: 223
Back to company
BioNTech SE
Annual Report
The report highlights BioNTech's extraordinarily successful 2021 financial year, marked by its historic contribution to containing the COVID-19 pandemic through the delivery of approximately 2.6 billion vaccine doses globally. The company transitioned into a fully integrated biopharmaceutical powerhouse, recording EUR 19 billion in revenues and expanding its global footprint. In oncology, BioNTech advanced its pipeline with four randomized Phase 2 trials and five first-in-human studies. Additionally, the company committed to climate protection by setting targets aligned with the Science Based Targets initiative, aiming for a 42% reduction in Scope 1 and 2 emissions by 2030.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Net Zero Target
Employees